Reported Wednesday, Nutex Health Gains Shareholder Approval For Reverse Stock Split, Aiming For NASDAQ Compliance

6/20/24 6:15:52 AM ET

Business Services

Consumer Discretionary

Get the next $NUTX alert in real time by email

Nutex Health a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, announced that during its annual shareholder meeting yesterday, it obtained approval from its shareholders to effect a reverse stock split of between 1-for-2 to 1-for-16.

Get the next $NUTX alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NUTX

Date	Price Target	Rating	Analyst
11/12/2024	$45.00 → $50.00	Buy	Maxim Group
9/18/2024	$45.00	Buy	Maxim Group
2/22/2023	$3.00	Outperform	Northland Capital

More analyst ratings

$NUTX
Press Releases

Fastest customizable press release news feed in the world

NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN
NUTEX HEALTH CONTINUES TO EXPAND ITS NATIONAL FOOTPRINT WITH ITS THIRD HOSPITAL OPENING IN 2024 HOUSTON, Nov. 18, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 23 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in ten states and primary care-centric, risk-bearing physician networks, today announced the opening of Milwaukee ER & Hospital, located at 1751 W Layton Ave, Milwaukee, WI 53221. The staff of medical experts at Milwaukee ER & Hospital are bringing the community 24/7/365 days of concierge-level care. The 20,000 square foot state-of-the-art facilit
11/18/24 5:30:00 AM ET
$NUTX
Business Services
Consumer Discretionary
NUTEX HEALTH REPORTS THIRD QUARTER AND YEAR TO DATE SEPTEMBER 30, 2024 FINANCIAL RESULTS
TOTAL REVENUE OF $222.3 MILLION FOR THE FIRST NINE MONTHS OF 2024 VS. $178.0 MILLION FOR THE SAME PERIOD IN 2023, AN INCREASE OF 25%HOSPITAL DIVISION VISITS OF 122,944 FOR THE FIRST NINE MONTHS OF 2024 VS. VISITS OF 102,798 FOR THE SAME PERIOD IN 2023, AN INCREASE OF 20%HOSPITAL DIVISION OPERATING INCOME OF $54.7 MILLION FOR THE FIRST NINE MONTHS OF 2024 VS. $21.1 MILLION FOR THE SAME PERIOD IN 2023, AN INCREASE OF 159%NET CASH FROM OPERATING ACTIVITIES OF $23.1 MILLION FOR THE FIRST NINE MONTHS OF 2024COMPANY CONTINUES ITS FOCUS ON INCREASING CASH FLOWHOUSTON, Nov. 7, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthca
11/7/24 5:09:00 PM ET
$NUTX
Business Services
Consumer Discretionary
NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
HOUSTON, Nov. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET. Participant Listening: 1-877-407-9208 or 1-201-493-6784 Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1691722&tp_key=bfd69ce
11/5/24 5:30:00 AM ET
$NUTX
Business Services
Consumer Discretionary

NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
HOUSTON, Nov. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET. Participant Listening: 1-877-407-9208 or 1-201-493-6784 Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1691722&tp_key=bfd69ce
11/5/24 5:30:00 AM ET
$NUTX
Business Services
Consumer Discretionary
NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
HOUSTON, Nov. 1, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET. Participant Listening: 1-877-407-9208 or 1-201-493-6784 Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1681991&tp_key=79ea06
11/1/24 5:30:00 AM ET
$NUTX
Business Services
Consumer Discretionary
NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
HOUSTON, Aug. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2024 after the close of the stock market on Thursday, August 8, 2024. The Company will discuss those results on a conference call on Friday, August 9, 2024 at 10:00 am ET. Participant Dial-In Numbers: 1-877-407-9208 or 1-201-493-6784 Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1681991&tp_key=79ea06250d
8/5/24 7:26:00 PM ET
$NUTX
Business Services
Consumer Discretionary

$NUTX
Leadership Updates

Live Leadership Updates

NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS
HOUSTON, April 22, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Scott J. Saunders, and Kelvin Spears, MD, to its Board of Directors. They replace John Waters, who recently passed away, and Dr. Daniel Stites, who fulfilled his one-year term Board commitment. The Board has determined that Mr. Saunders satisfies the current independent director standards established by the rules of The Nasdaq Stock Market. Mr. Saunders will s
4/22/24 5:30:00 AM ET
$NUTX
Business Services
Consumer Discretionary
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JOSHUA DETILLIO AS ITS NEW CHIEF OPERATING OFFICER
HOUSTON, Sept. 5, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Joshua DeTillio as the Company's Chief Operating Officer effective on or about October 2, 2023. Mr. DeTillio is an experienced healthcare leader with over 20 years of hospital experience and 12 years as a CEO in investor-owned, publicly traded companies. He has demonstrated success in collaborating with and leading boards and physicians to drive growth, improve c
9/5/23 5:30:00 AM ET
$NUTX
Business Services
Consumer Discretionary
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JON BATES AS ITS NEW CHIEF FINANCIAL OFFICER
HOUSTON, June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, today announced the appointment of Jon Bates as the Company's Chief Financial Officer effective on or about June 30, 2022. On May 3, 2022, Michael Bowen notified the company that he intends to retire as Chief Financial Officer of the Company. In connection with Mr. Bowen's retirement, the Company's Board formed a search committee. On June 8, 2022, the Company announced the appointme
6/10/22 6:00:00 AM ET
$NUTX
$USPH
Business Services
Consumer Discretionary
Medical/Nursing Services
Health Care

Reported Wednesday, Nutex Health Gains Shareholder Approval For Reverse Stock Split, Aiming For NASDAQ Compliance

Chat with this insight

Recent Analyst Ratings for $NUTX

$NUTX Press Releases

Fastest customizable press release news feed in the world

NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN

NUTEX HEALTH REPORTS THIRD QUARTER AND YEAR TO DATE SEPTEMBER 30, 2024 FINANCIAL RESULTS

NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL

$NUTX Market Insights

Live Market Insights

Nutex Health Announces 1-For-10 Reverse Stock Split, Effective With The Market Opening On Wednesday, July 3, 2024

Reported Wednesday, Nutex Health Gains Shareholder Approval For Reverse Stock Split, Aiming For NASDAQ Compliance

On June 14, Nutex Health Got Notice From Nasdaq That Co Was Granted Exception Until July 22, 2024 To Effect Reverse Stock Split Of Its Common Stock

$NUTX Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Financial Officer Bates Jon Christian bought $28,970 worth of shares (1,350 units at $21.46), increasing direct ownership by 146% to 2,277 units (SEC Form 4)

Chief Operating Officer Detillio Joshua bought $10,800 worth of shares (20,000 units at $0.54), increasing direct ownership by 214% to 29,333 units (SEC Form 4)

Vo Thomas T. bought $50,366 worth of shares (72,478 units at $0.69) (SEC Form 4)

$NUTX SEC Filings

Nutex Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form 10-Q filed by Nutex Health Inc.

Nutex Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$NUTX Financials

Live finance-specific insights

NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL

NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL

NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL

$NUTX Leadership Updates

Live Leadership Updates

NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JOSHUA DETILLIO AS ITS NEW CHIEF OPERATING OFFICER

NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JON BATES AS ITS NEW CHIEF FINANCIAL OFFICER

$NUTX Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Nutex Health Inc.

SEC Form SC 13G/A filed by Nutex Health Inc. (Amendment)

SEC Form SC 13G filed by Nutex Health Inc.

$NUTX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Financial Officer Bates Jon Christian bought $28,970 worth of shares (1,350 units at $21.46), increasing direct ownership by 146% to 2,277 units (SEC Form 4)

SEC Form 4 filed by Nutex Health Inc.

Chief Executive Officer Vo Thomas T. was granted 22,709 shares (SEC Form 4)

$NUTX Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Maxim Group reiterated coverage on Nutex Health with a new price target

Maxim Group initiated coverage on Nutex Health with a new price target

Northland Capital initiated coverage on Nutex Health with a new price target

Recent Analyst Ratings for
$NUTX

$NUTX
Press Releases

$NUTX
Market Insights

$NUTX
Insider Purchases

$NUTX
SEC Filings

$NUTX
Financials

$NUTX
Leadership Updates

$NUTX
Large Ownership Changes

$NUTX
Insider Trading

$NUTX
Analyst Ratings